BCAX
Bicara Therapeutics Inc.
+0.45 (+2.05%)22.45USD165K成交股數1.5B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-10下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | 33.0M | 24.8M | 34.3M | 15.9M | 15.8M | 12.0M | – | 6.9M | – |
| 銷售管理費用 | 14.2M | 12.7M | 8.1M | 7.7M | 7.2M | 7.5M | 4.8M | 3.9M | 3.3M | – | 2.6M | – |
| 營業利益 | −60.0M+87% | −60.2M+44% | −41.1M+99% | −40.7M+106% | −32.0M+108% | −41.8M | −20.6M+116% | −19.8M | −15.4M | – | −9.5M | – |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −55.4M+102% | −56.2M+53% | −37.4M+114% | −36.3M+113% | −27.4M+119% | −36.8M+196% | −17.5M-23% | −17.0M+84% | −12.5M | −12.4M | −22.8M | −9.3M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.82+64% | -0.93+37% | -0.67-58% | -0.67-96% | -0.50-97% | -0.68 | -1.60-96% | -19.01 | -18.94 | – | -38.23 | – |
| 稀釋股數 | 67.9M | 60.7M | 54.68B | 54.6M | 54.5M | 54.5M | 10.9M | 897K | 660K | 580M | 598K | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 96.6M | 323M | 96.7M | 172M | 437M | 462M | 521M | 204M | 216M | 230M | 44.2M | – |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 512M | 554M | 431M | 425M | 454M | 478M | 524M | – | – | 234M | – | – |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 43.5M | 39.6M | 29.5M | 21.9M | 18.4M | 19.1M | 14.6M | – | – | 15.5M | – | – |
| 股東權益 | 469M | 514M | 401M | 403M | 435M | 459M | 510M | −175M | −160M | −149M | −137M | −115M |
| 負債比 | 8.5% | 7.2% | 6.9% | 5.2% | 4.1% | 4.0% | 2.8% | – | – | 6.6% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −37.5M+33% | – | – | – | −28.1M | – | – | −14.6M | – | – | – |
| 資本支出 | – | 60K | – | – | – | 0 | – | – | 4K | – | – | – |
| 自由現金流 | – | −37.6M+34% | – | – | – | −28.1M | – | – | −14.6M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −138M | –% | -2.52 | −107M |
| FY2024 | – | – | −68.0M | –% | -4.05 | −74.8M |
| FY2023 | – | – | −52.0M | –% | -89.61 | −46.2M |